The emergence and evolution of methicillin-resistant Staphylococcus aureus

被引:579
作者
Hiramatsu, K [1 ]
Cui, L [1 ]
Kuroda, M [1 ]
Ito, T [1 ]
机构
[1] Juntendo Univ, Dept Bacteriol, Bunkyo Ku, Tokyo 1138421, Japan
基金
日本学术振兴会;
关键词
D O I
10.1016/S0966-842X(01)02175-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significant advances have been made in recent years in our understanding of how methicillin resistance is acquired by Staphylococcus aureus. Integration of a staphylococcal cassette chromosome mec(SCCmec) element into the chromosome converts drug-sensitive S. aureus into the notorious hospital pathogen methicilin-resistant S. aureus(MRSA), which is resistant to practically all beta -lactam antibiotics. SCCmec is a novel class of mobile genetic element that is composed of the mec gene complex encoding methicillin resistance and the ccr gene complex that encodes recombinases responsible for its mobility. These elements also carry various resistance genes for non-beta -lactam antibiotics. After acquiring an SCCmec element, MRSA undergoes several mutational events and evolves into the most difficult-to-treat pathogen in hospitals, against which all extant antibiotics including vancomycin are ineffective. Recent epidemiological data imply that MRSA has embarked on another evolutionary path as a community pathogen, as at least one novel SCCmec element seems to have been successful in converting S. aureus strains from the normal human flora into MRSA.
引用
收藏
页码:486 / 493
页数:8
相关论文
共 48 条
[1]  
[Anonymous], 1999, MMWR-MORBID MORTAL W, V48, P707
[2]  
[Anonymous], 1995, J INFECT CHEMOTHER
[3]   Characterization of IS1272, an insertion sequence-like element from Staphylococcus haemolyticus [J].
Archer, GL ;
Thanassi, JA ;
Niemeyer, DM ;
Pucci, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) :924-929
[4]   Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany [J].
Bierbaum, G ;
Fuchs, K ;
Lenz, W ;
Szekat, C ;
Sahl, HG .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (10) :691-696
[5]   The changing epidemiology of Staphylococcus aureus? [J].
Chambers, HF .
EMERGING INFECTIOUS DISEASES, 2001, 7 (02) :178-182
[6]   Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals [J].
Chesneau, O ;
Morvan, A ;
El Solh, N .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (06) :887-890
[7]   CONSTITUTIVE PENICILLINASE FORMATION IN STAPHYLOCOCCUS AUREUS OWING TO A MUTATION UNLINKED TO PENICILLINASE PLASMID [J].
COHEN, S ;
SWEENEY, HM .
JOURNAL OF BACTERIOLOGY, 1968, 95 (04) :1368-&
[8]   Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50 [J].
Cui, LZ ;
Murakami, H ;
Kuwahara-Arai, K ;
Hanaki, H ;
Hiramatsu, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2276-2285
[9]   ABNORMAL PEPTIDOGLYCAN PRODUCED IN A METHICILLIN-RESISTANT STRAIN OF STAPHYLOCOCCUS-AUREUS GROWN IN THE PRESENCE OF METHICILLIN - FUNCTIONAL-ROLE FOR PENICILLIN-BINDING PROTEIN-2A IN CELL-WALL SYNTHESIS [J].
DEJONGE, BLM ;
TOMASZ, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (02) :342-346
[10]  
Ferraz V, 2000, S AFR MED J, V90, P1113